000137652 001__ 137652
000137652 005__ 20240321220304.0
000137652 0247_ $$2doi$$a10.1212/WNL.0000000000000865
000137652 0247_ $$2pmid$$apmid:25194012
000137652 0247_ $$2ISSN$$a0028-3878
000137652 0247_ $$2ISSN$$a1526-632X
000137652 0247_ $$2altmetric$$aaltmetric:2662328
000137652 037__ $$aDZNE-2020-03974
000137652 041__ $$aEnglish
000137652 082__ $$a610
000137652 1001_ $$0P:(DE-2719)2810931$$aPrüss, Harald$$b0$$eFirst author$$udzne
000137652 245__ $$aLimbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia.
000137652 260__ $$a[S.l.]$$bOvid$$c2014
000137652 264_1 $$2Crossref$$3online$$bOvid Technologies (Wolters Kluwer Health)$$c2014-09-05
000137652 264_1 $$2Crossref$$3print$$bOvid Technologies (Wolters Kluwer Health)$$c2014-10-07
000137652 3367_ $$2DRIVER$$aarticle
000137652 3367_ $$2DataCite$$aOutput Types/Journal article
000137652 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1594206632_24854
000137652 3367_ $$2BibTeX$$aARTICLE
000137652 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000137652 3367_ $$00$$2EndNote$$aJournal Article
000137652 536__ $$0G:(DE-HGF)POF3-342$$a342 - Disease Mechanisms and Model Systems (POF3-342)$$cPOF3-342$$fPOF III$$x0
000137652 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x1
000137652 588__ $$aDataset connected to CrossRef, PubMed,
000137652 650_7 $$2NLM Chemicals$$aAutoantibodies
000137652 650_7 $$2NLM Chemicals$$aGRM5 protein, human
000137652 650_7 $$2NLM Chemicals$$aImmunoglobulin G
000137652 650_7 $$2NLM Chemicals$$aReceptor, Metabotropic Glutamate 5
000137652 650_7 $$0X4W7ZR7023$$2NLM Chemicals$$aMethylprednisolone
000137652 650_2 $$2MeSH$$aAdult
000137652 650_2 $$2MeSH$$aAutoantibodies: blood
000137652 650_2 $$2MeSH$$aAutoantibodies: cerebrospinal fluid
000137652 650_2 $$2MeSH$$aFemale
000137652 650_2 $$2MeSH$$aHumans
000137652 650_2 $$2MeSH$$aImmunoglobulin G: blood
000137652 650_2 $$2MeSH$$aImmunoglobulin G: cerebrospinal fluid
000137652 650_2 $$2MeSH$$aLimbic Encephalitis: blood
000137652 650_2 $$2MeSH$$aLimbic Encephalitis: cerebrospinal fluid
000137652 650_2 $$2MeSH$$aLimbic Encephalitis: complications
000137652 650_2 $$2MeSH$$aLimbic Encephalitis: drug therapy
000137652 650_2 $$2MeSH$$aLimbic Encephalitis: immunology
000137652 650_2 $$2MeSH$$aLimbic Encephalitis: therapy
000137652 650_2 $$2MeSH$$aMethylprednisolone: therapeutic use
000137652 650_2 $$2MeSH$$aPlasma Exchange
000137652 650_2 $$2MeSH$$aProsopagnosia: blood
000137652 650_2 $$2MeSH$$aProsopagnosia: cerebrospinal fluid
000137652 650_2 $$2MeSH$$aProsopagnosia: complications
000137652 650_2 $$2MeSH$$aProsopagnosia: drug therapy
000137652 650_2 $$2MeSH$$aProsopagnosia: immunology
000137652 650_2 $$2MeSH$$aProsopagnosia: therapy
000137652 650_2 $$2MeSH$$aReceptor, Metabotropic Glutamate 5: drug effects
000137652 650_2 $$2MeSH$$aReceptor, Metabotropic Glutamate 5: immunology
000137652 7001_ $$aRothkirch, Marcus$$b1
000137652 7001_ $$aKopp, Ute$$b2
000137652 7001_ $$aHamer, Hajo M$$b3
000137652 7001_ $$aHagge, Mareike$$b4
000137652 7001_ $$aSterzer, Phillipp$$b5
000137652 7001_ $$aSaschenbrecker, Sandra$$b6
000137652 7001_ $$aStöcker, Winfried$$b7
000137652 7001_ $$aHarms, Lutz$$b8
000137652 7001_ $$0P:(DE-2719)2811033$$aEndres, Matthias$$b9$$eLast author$$udzne
000137652 77318 $$2Crossref$$3journal-article$$a10.1212/wnl.0000000000000865$$b : Ovid Technologies (Wolters Kluwer Health), 2014-09-05$$n15$$p1384-1386$$tNeurology$$v83$$x0028-3878$$y2014
000137652 773__ $$0PERI:(DE-600)1491874-2$$a10.1212/WNL.0000000000000865$$gVol. 83, no. 15, p. 1384 - 1386$$n15$$p1384-1386$$q83:15<1384 - 1386$$tNeurology$$v83$$x0028-3878$$y2014
000137652 909CO $$ooai:pub.dzne.de:137652$$pVDB
000137652 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810931$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000137652 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811033$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000137652 9131_ $$0G:(DE-HGF)POF3-342$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$aDE-HGF$$bForschungsbereich Gesundheit$$lErkrankungen des Nervensystems$$vDisease Mechanisms and Model Systems$$x0
000137652 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$aDE-HGF$$bForschungsbereich Gesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x1
000137652 9141_ $$y2014
000137652 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz
000137652 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROLOGY : 2017
000137652 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000137652 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000137652 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000137652 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000137652 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000137652 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000137652 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000137652 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000137652 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000137652 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000137652 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000137652 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROLOGY : 2017
000137652 9201_ $$0I:(DE-2719)1810003$$kAG Prüß$$lAutoimmune Enzephalopathies$$x0
000137652 9201_ $$0I:(DE-2719)1811005$$kAG Endres$$lCoordinator of Clinical Research$$x1
000137652 980__ $$ajournal
000137652 980__ $$aVDB
000137652 980__ $$aI:(DE-2719)1810003
000137652 980__ $$aI:(DE-2719)1811005
000137652 980__ $$aUNRESTRICTED